Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
RSP vs VLUE: how they differ
RSP and VLUE hold 24% of their weight in the same names, and VLUE returned more over the year.
Invesco S&P 500 Equal Weight ETF and iShares MSCI USA Value Factor ETF.
What they hold in common
By the books each fund has filed, RSP and VLUE hold 24% of their money in the same securities at the same weight.
| Holding | RSP | VLUE |
|---|---|---|
| Intel Corp. | 0.38% | 9.29% |
| ON Semiconductor Corp. | 0.33% | 0.78% |
| Western Digital Corp. | 0.31% | 1.89% |
| Centene Corp. | 0.29% | 0.31% |
| NXP Semiconductors N.V. | 0.28% | 1.00% |
| Dell Technologies Inc. | 0.27% | 0.86% |
| Hewlett Packard Enterprise Co. | 0.26% | 1.30% |
| QUALCOMM Inc. | 0.26% | 1.80% |
| Jabil Inc. | 0.26% | 0.57% |
| Nucor Corp. | 0.25% | 0.38% |
| Elevance Health, Inc. | 0.25% | 0.63% |
| Micron Technology, Inc. | 0.24% | 11.63% |
| Only in RSP | Only in VLUE |
|---|---|
| Seagate Technology Holdings PLC 0.34% | ZOOM COMMUNICATIONS, INC. 0.53% |
| Advanced Micro Devices, Inc. 0.33% | TWILIO INC. 0.35% |
| Sandisk Corp. 0.32% | STRATEGY INC 0.30% |
| Ciena Corp. 0.30% | FLEX LTD. 0.25% |
| Monolithic Power Systems, Inc. 0.29% | W.P. CAREY INC. 0.25% |
| Microchip Technology Inc. 0.27% | ROYALTY PHARMA PLC 0.24% |
| Texas Instruments Inc. 0.27% | SS&C TECHNOLOGIES HOLDINGS, INC. 0.21% |
| Lumentum Holdings Inc. 0.26% | UNITED THERAPEUTICS CORPORATION 0.18% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026.
| RSP Invesco S&P 500 Equal Weight ETF | VLUE iShares MSCI USA Value Factor ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Invesco | iShares |
| What it is | S&P 500 equal weight | MSCI USA Value Factor |
| Total return, 1 year | +14.8% | +69.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −2.7 pts | +51.9 pts |
| Expense ratio | 0.20% | 0.15% |
| Already in the S&P 500 | 99.1% | 96.9% |
| Holdings | 503 | 148 |
RSP in plain words
RSP is an index equity fund tracking the S&P 500 equal weight. Over the year to Sep 11, 2026 it returned +14.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.20% a year. By its holdings filed for Apr 30, 2026, 99% of the fund by weight is stocks the S&P 500 also holds, across 503 positions, with the top ten at 3.2%. It sat 3.5% below its high of Aug 14, 2026 on Sep 11, 2026.
VLUE in plain words
VLUE is an index equity fund tracking the MSCI USA Value Factor. Over the year to Sep 11, 2026 it returned +69.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year. By its holdings filed for Apr 30, 2026, 97% of the fund by weight is stocks the S&P 500 also holds, across 148 positions, with the top ten at 43.6%.
Questions people ask
- Which returned more over the last year, RSP or VLUE?
- In the year to Sep 12, 2026, with distributions reinvested, RSP returned +14.8% and VLUE returned +69.4%, so VLUE returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, RSP or VLUE?
- RSP charges 0.20% a year and VLUE charges 0.15%, so VLUE is cheaper. Fees come from each fund's prospectus.
- How much do RSP and VLUE overlap with the S&P 500?
- By their latest filed holdings, 99% of RSP and 97% of VLUE by weight is stocks the S&P 500 already holds. Between the two funds, 24% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, RSP against VLUE, data as of Sep 12, 2026. https://etfiq.com/compare/any/RSP-VLUE Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources